Actively Recruiting

Age: 18Years +
All Genders
NCT05837260

Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer

Led by Royal Marsden NHS Foundation Trust · Updated on 2024-08-09

120

Participants Needed

1

Research Sites

202 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Although most thyroid cancers are treated and cured successfully there are still 30% who recur after many years. This will eventually progress and at this point may become incurable with treatment options including complex and high risk surgery. The overall efficacy of systemic treatment in advanced thyroid cancer has a good initial response in most patients but not all. The study will collect tissues and blood samples for various protein analysis, nucleic acid extraction and live cell analysis in order to try and detect the presence of plasma ctDNA at baseline of eligible patients.

CONDITIONS

Official Title

Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosis of radioiodine refractory differentiated thyroid carcinoma under surveillance
  • Newly diagnosed resectable locally advanced medullary thyroid cancer or metastatic medullary thyroid cancer under surveillance
  • Locally advanced or metastatic medullary thyroid cancer on surveillance
  • Radioiodine refractory differentiated thyroid carcinoma starting or on systemic therapy
  • Medullary thyroid cancer starting or on systemic therapy
  • Newly diagnosed anaplastic thyroid cancer
  • Availability of archival tumor tissue or willingness to have biopsy of accessible disease
  • Willingness to undergo standard monitoring and treatment as recommended
  • Ability to give informed consent for biological sample collection
Not Eligible

You will not qualify if you...

  • Any illness that would interfere with complete sample collection
  • Any invasive malignancy within the past 5 years except non-melanomatous skin carcinoma or carcinoma in situ
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Royal Marsden NHS Foundation Trust

London, United Kingdom, SW3 6JJ

Actively Recruiting

Loading map...

Research Team

L

Leslie Cheng

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here